VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
This Quarter Return
+4.29%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$1.24B
AUM Growth
+$1.24B
(-33%)
Cap. Flow
-$662M
Cap. Flow
% of AUM
-53.24%
Top 10 Holdings %
Top 10 Hldgs %
19.67%
Holding
716
New
21
Increased
155
Reduced
258
Closed
281
Top Buys
| 1 |
Omnicell
OMCL
|
$13.7M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$10.3M |
| 3 |
BEAT
BioTelemetry, Inc.
BEAT
|
$4.01M |
| 4 |
iRobot
IRBT
|
$3.95M |
| 5 |
3D Systems Corporation
DDD
|
$3.68M |
Top Sells
| 1 |
Lincoln Electric
LECO
|
$12.9M |
| 2 |
Azenta
AZTA
|
$7.86M |
| 3 |
Oceaneering
OII
|
$5.24M |
| 4 |
Prologis
PLD
|
$4.21M |
| 5 |
PSB
PS Business Parks, Inc.
PSB
|
$4.04M |
Sector Composition
| 1 | Technology | 28.66% |
| 2 | Healthcare | 14.8% |
| 3 | Industrials | 9.62% |
| 4 | Consumer Discretionary | 5.64% |
| 5 | Consumer Staples | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Fate Therapeutics
FATE
$118M
| $1.68M | 0.14% |
82,719
-13,596
| -14% | -$276K |
|
|
ONC
102
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.68M | 0.14% |
13,546
-234
| -2% | -$29K |
|
103
Kroger
KR
$44.7B
| $1.67M | 0.13% |
76,852
-84,683
| -52% | -$1.84M |
|
104
MarketAxess Holdings
MKTX
$6.75B
| $1.66M | 0.13% |
5,166
-1,283
| -20% | -$412K |
|
105
Evergy
EVRG
$16.3B
| $1.65M | 0.13% |
27,431
+1,656
| +6% | +$99.6K |
|
106
argenx
ARGX
$43.8B
| $1.64M | 0.13% |
11,546
-3,414
| -23% | -$483K |
|
107
Alaunos Therapeutics
TCRT
$4.79M
| $1.62M | 0.13% |
+278,609
| New | +$1.62M |
|
108
MacroGenics
MGNX
$120M
| $1.61M | 0.13% |
94,915
-9,856
| -9% | -$167K |
|
109
NextEra Energy, Inc.
NEE
$147B
| $1.6M | 0.13% |
7,786
-239
| -3% | -$49K |
|
110
Regeneron Pharmaceuticals
REGN
$61.7B
| $1.59M | 0.13% |
5,088
+655
| +15% | +$205K |
|
111
Cboe Global Markets
CBOE
$24.4B
| $1.58M | 0.13% |
15,262
-115
| -0.7% | -$11.9K |
|
112
Zymeworks
ZYME
$1.07B
| $1.56M | 0.13% |
+71,026
| New | +$1.56M |
|
113
IBM
IBM
$225B
| $1.56M | 0.13% |
11,302
+28
| +0.2% | +$3.86K |
|
114
Clorox
CLX
$14.9B
| $1.55M | 0.12% |
10,139
+114
| +1% | +$17.5K |
|
115
Precision BioSciences
DTIL
$58.9M
| $1.55M | 0.12% |
+116,951
| New | +$1.55M |
|
116
CRISPR Therapeutics
CRSP
$4.87B
| $1.55M | 0.12% |
+32,833
| New | +$1.55M |
|
117
Sempra
SRE
$53.3B
| $1.55M | 0.12% |
11,246
-544
| -5% | -$74.8K |
|
118
Ventas
VTR
$30.8B
| $1.54M | 0.12% |
22,489
-19,070
| -46% | -$1.3M |
|
119
Y-mAbs Therapeutics
YMAB
$389M
| $1.52M | 0.12% |
66,416
-5,450
| -8% | -$125K |
|
120
AstraZeneca
AZN
$253B
| $1.5M | 0.12% |
36,430
-3,900
| -10% | -$161K |
|
|
BLUE
121
DELISTED
bluebird bio
BLUE
| $1.49M | 0.12% |
11,729
-3,675
| -24% | -$467K |
|
122
Allogene Therapeutics
ALLO
$255M
| $1.46M | 0.12% |
54,332
-4,998
| -8% | -$134K |
|
|
SGEN
123
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.46M | 0.12% |
21,084
-4,259
| -17% | -$295K |
|
|
AUTL
124
Autolus Therapeutics
AUTL
$397M
| $1.46M | 0.12% |
+90,425
| New | +$1.46M |
|
125
Chevron
CVX
$318B
| $1.45M | 0.12% |
11,624
-20,773
| -64% | -$2.59M |
|